Dublin, Jan. 26, 2017 -- Research and Markets has announced the addition of the "Foot and Ankle Devices Market Analysis & Trends - Product (Prostheses, Bracing and Support Devices and Orthopedic Implants and Devices ), Cause of Injury (Neurological Disorders, Trauma and Diabetes) - Forecast to 2025" report to their offering.
The Global Foot and Ankle Devices Market is poised to grow at a CAGR of around 7.9% over the next decade to reach approximately $7.82 billion by 2025.
Some of the prominent trends that the market is witnessing include increasing numerous sports injuries, growing geriatric population worldwide and increasing new product launches.
Based on product the market is categorized into prostheses, bracing and support devices and orthopedic implants and devices. Prostheses segment is further segmented into Microprocessor-Controlled (MPC) prostheses, Solid Ankle Cushion Heel (SACH) foot, multiaxial prostheses, single-axial prostheses, dynamic response/energy-storing prostheses. Bracing and support devices are further segregated into hinged braces and soft bracing. Orthopedic implants and devices segment is further classified into soft-tissue orthopedic devices, joint implants and fixation devices.
Depending on the cause of injury the market is segmented by neurological disorders, trauma, diabetes and other causes.
This industry report analyzes the global markets for Foot and Ankle Devices across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.
The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.
Key Topics Covered:
1 Market Outline
2 Executive Summary
3 Market Overview
3.1 Current Trends
3.1.1 Increasing Numerous Sports Injuries
3.1.2 Growing Geriatric Population Worldwide
3.1.3 Increasing New Product Launches
3.1.4 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness
4 Foot and Ankle Devices Market, By Product
4.1 Prostheses
4.1.1.1 Microprocessor-Controlled (MPC) Prostheses
4.1.1.2 Solid Ankle Cushion Heel (SACH) Foot
4.1.1.3 Multiaxial Prostheses
4.1.1.4 Single-Axial Prostheses
4.1.1.5 Dynamic Response/Energy-Storing Prostheses
4.2 Bracing and Support Devices
4.2.1.1 Hinged Braces
4.2.1.2 Soft Bracing
4.3 Orthopedic Implants and Devices
4.3.1.1 Soft-Tissue Orthopedic Devices
4.3.1.1.1.1 Musculoskeletal Reinforcement Devices
4.3.1.1.1.2 Artificial Tendons & Ligaments
4.3.1.2 Joint Implants
4.3.1.2.1.1 Phalangeal Implants
4.3.1.2.1.2 Ankle Implants (Ankle Replacement Devices)
4.3.1.2.1.3 Subtalar Joint Implants/Subtalar Joint Reconstruction Devices
4.3.1.3 Fixation Devices
4.3.1.3.1.1 Internal Fixation Devices
4.3.1.3.1.1.1.1 Fusion Nails
4.3.1.3.1.1.1.2 Screws
4.3.1.3.1.1.1.3 Plates
4.3.1.3.1.1.1.4 Wires & Pins
4.3.1.3.1.2 External Fixation Devices
4.3.1.3.1.2.1.1 Ring Ankle Fixators
4.3.1.3.1.2.1.2 Unilateral Fixators
4.3.1.3.1.2.1.3 Hybrid Fixators
5 Foot and Ankle Devices Market, By Cause of Injury
5.1 Neurological Disorders
5.2 Trauma
5.3 Diabetes
5.4 Other Causes
6 Foot and Ankle Devices Market, By Geography
7 Leading Companies
7.1 Acumed, LLC
7.2 Arthrex, Inc.
7.3 Extremity Medical, LLC
7.4 Integra Lifesciences Holdings Corporation
7.5 Ossur
7.6 Smith & Nephew PLC.
7.7 Stryker Corporation
7.8 Tornier N.V.
7.9 Wright Medical Technology, Inc.
7.10 Zimmer Biomet Holdings, Inc.
7.11 De Puy Synthes
7.12 Biomet, Inc.
7.13 BioPro, Inc.
7.14 Orthofix Holdings Inc.
7.15 Mondeal Medical Systems GmbH
For more information about this report visit http://www.researchandmarkets.com/research/kphvcg/foot_and_ankle
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Medical Devices, Orthopedic Devices, Diabetes Devices


FDA Approves Mitapivat for Anemia in Thalassemia Patients
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
BP Nears $10 Billion Castrol Stake Sale to Stonepeak 



